Neris Almeida Viana: Benefits of probiotic use on COVID-19: A systematic review and meta-analysis [Probiotics]

Benefits of probiotic use on COVID-19: A systematic review and meta-analysis

Neris Almeida Viana et al., Critical Reviews in Food Science and Nutrition, doi:10.1080/10408398.2022.2128713 (meta analysis)

Neris Almeida Viana et al., Benefits of probiotic use on COVID-19: A systematic review and meta-analysis, Critical Reviews in Food Science and Nutrition, doi:10.1080/10408398.2022.2128713 (meta analysis)

Sep 2022 Source PDF

Twitter
Facebook

All Studies Meta

Systematic review and meta analysis showing significant improvement in symptoms with priobiotic treatment.

Currently there are 22 probiotics studies and meta analysis shows:

Outcome	Improvement
Mortality	61% lower [37‑76%]
Ventilation	38% lower [-87‑79%]
ICU admission	21% lower [-20‑48%]
Hospitalization	13% lower [5‑21%]
Cases	31% fewer [-1‑53%]

Important missing comments or errors? Let us know.

risk of no recovery, 51.0% lower, RR 0.49, p < 0.001, symptoms.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Neris Almeida Viana et al., 30 Sep 2022, peer-reviewed, 7 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Probiotics All

Download Image

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit